Pilonidal Cyst/Fistula Clinical Trial
Official title:
Secondary Intention Wound Healing, in Patients Subjected to Surgical Resection of Pilonidal Cyst, Using Alginate Dressings With Silver and High-G Cellulose, Compared to the Use of Simple Gauze Dressings: Examination of the Quality of Life
Verified date | May 2021 |
Source | Larissa University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to compare the application of alginate dressings with silver and high-G cellulose and the use of simple gauge dressings in patients submitted to surgical resection of pilonidal cyst. The present trial will focus on the postoperative quality of life during the secondary intention wound healing.
Status | Terminated |
Enrollment | 65 |
Est. completion date | April 25, 2021 |
Est. primary completion date | February 25, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Male or female - Pilonidal cyst - Age: 18 to 80 years - American Society of Anesthesiologists (ASA) score: I, II, III, IV - Disease stage I,II,III and IV Exclusion Criteria: - Pilonidal abscess - Patient age = 80 years or < 18 years - Pilonidal abscess |
Country | Name | City | State |
---|---|---|---|
Greece | University Hospital of Larissa | Larissa |
Lead Sponsor | Collaborator |
---|---|
Larissa University Hospital | University of Thessaly |
Greece,
Al-Salamah SM, Hussain MI, Mirza SM. Excision with or without primary closure for pilonidal sinus disease. J Pak Med Assoc. 2007 Aug;57(8):388-91. — View Citation
Anagnostopoulos F, Niakas D, Pappa E. Construct validation of the Greek SF-36 Health Survey. Qual Life Res. 2005 Oct;14(8):1959-65. — View Citation
Armstrong JH, Barcia PJ. Pilonidal sinus disease. The conservative approach. Arch Surg. 1994 Sep;129(9):914-7; discussion 917-9. — View Citation
Berry DP. Pilonidal sinus disease. J Wound Care. 1992 Sep 2;1(3):29-32. — View Citation
Blanco G, Giordano M, Torelli I. [Surgical treatment of pilonidal sinus with open surgical technique]. Minerva Chir. 2003 Apr;58(2):181-7. Review. Italian. — View Citation
Blome C, Baade K, Debus ES, Price P, Augustin M. The "Wound-QoL": a short questionnaire measuring quality of life in patients with chronic wounds based on three established disease-specific instruments. Wound Repair Regen. 2014 Jul-Aug;22(4):504-14. doi: 10.1111/wrr.12193. — View Citation
BUIE LA, CURTISS RK. Pilonidal disease. Surg Clin North Am. 1952 Aug:1247-59. — View Citation
Clothier PR, Haywood IR. The natural history of the post anal (pilonidal) sinus. Ann R Coll Surg Engl. 1984 May;66(3):201-3. — View Citation
Deutsch CJ, Edwards DM, Myers S. Wound dressings. Br J Hosp Med (Lond). 2017 Jul 2;78(7):C103-C109. doi: 10.12968/hmed.2017.78.7.C103. — View Citation
DWIGHT RW, MALOY JK. Pilonidal sinus; experience with 449 cases. N Engl J Med. 1953 Dec 3;249(23):926-30. — View Citation
Gruessner U, Clemens M, Pahlplatz PV, Sperling P, Witte J, Rosen HR; Septocoll Study Group. Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am J Surg. 2001 Nov;182(5):502-9. — View Citation
Irkörücü O, Erdem H, Reyhan E. The best therapy for pilonidal disease: which management for which type? World J Surg. 2012 Mar;36(3):691-2. doi: 10.1007/s00268-011-1285-2. — View Citation
Karydakis GE. New approach to the problem of pilonidal sinus. Lancet. 1973 Dec 22;2(7843):1414-5. — View Citation
Kronborg O, Christensen K, Zimmermann-Nielsen C. Chronic pilonidal disease: a randomized trial with a complete 3-year follow-up. Br J Surg. 1985 Apr;72(4):303-4. — View Citation
Lewis R, Whiting P, ter Riet G, O'Meara S, Glanville J. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol Assess. 2001;5(14):1-131. Review. — View Citation
Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003 Mar;11 Suppl 1:S1-28. Review. — View Citation
Søndenaa K, Andersen E, Nesvik I, Søreide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis. 1995;10(1):39-42. — View Citation
Søndenaa K, Diab R, Nesvik I, Gullaksen FP, Kristiansen RM, Saebø A, Kømer H. Influence of failure of primary wound healing on subsequent recurrence of pilonidal sinus. combined prospective study and randomised controlled trial. Eur J Surg. 2002;168(11):614-8. — View Citation
* Note: There are 18 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wound healing time | Postoperative required time for wound healing. Measurement unit: days | Maximum time frame 50 days postoperatively | |
Secondary | Postoperative return to everyday activities | Time required for returning to everyday activities. Measurement unit: days | Maximum time frame 50 days postoperatively | |
Secondary | Postoperative pain level | Pain level after surgery, quantified with the use of the Visual Analogue Scale (0-10). Better outcome: 0, Worse outcome: 10. There will be no subscales or total scores. | 7, 14, 21, 28, 35, 42 and 49 days postoperatively | |
Secondary | Postoperative analgesics consumption | Number of analgesic pills consumed per day after surgery. Measurement unit: pills per day | 7, 14, 21, 28, 35, 42 and 49 days postoperatively | |
Secondary | Overall satisfaction level | Satisfaction level after surgery, quantified with the use of the Visual Analogue Scale (0-10). Better outcome: 10, Worse outcome: 0. There will be no subscales or total scores. | 50 days postoperatively | |
Secondary | Cost of the material | Overall cost of the dressings applied | Maximum time frame 50 days postoperatively | |
Secondary | Wound care visits | Number of required visits for postoperative wound care for each patient per week. | 7, 14, 21, 28, 35, 42 and 49 days postoperatively | |
Secondary | Trauma secretions | Trauma secretions leading to extra dressing care. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' | 7, 14, 21, 28, 35, 42 and 49 days postoperatively | |
Secondary | Wound contamination | Contamination of the wound trauma. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' | Maximum time frame 50 days postoperatively | |
Secondary | Wound erythema | Erythema of the wound. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' | Maximum time frame 50 days postoperatively | |
Secondary | Wound haematoma | Haematoma of the wound. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' | Maximum time frame 50 days postoperatively | |
Secondary | Disease recurrence | Disease recurrence rate. If such an episode occurs, then it will be defined as=1 'YES' If such an episode does not occur, then it will be defined as=0 'NO' | Maximum time frame 1 year postoperatively | |
Secondary | Difference in the quality of life of the patient | Difference in the quality of life of the patient based on the Quality of Life with Chronic Wounds Wounds (Qol) Questionnaire. 17 items in total. Each item quantified with the use of a Visual Ordinal Scale (0='not at all' to 4='very much'). Global score computed by averaging all items. In total 3 subscales calculated by averaging the respective items:
Body: Items #1 to #5. Psyche: Items #6 to #10. Everyday life: Items #11 to #16. |
7, 14 and 21 days potoperatively | |
Secondary | Medium term quality of life | Quality of life of the patient based on the Short Form 36 (SF-36) questionnaire. 36 items in total. The following ordinal scales will be used for the respective items:
1 (Better)-5 (Worse): #1, #2, #20, #22, #34, #36. 1 (Worse)-3 (Better): #3, to #12. 1 (Worse)-2 (Better): #13, to #19. 1 (Better)-6 (Worse): #21, #23, #26, #27, #30. 1 (Worse)-6 (Better): #24, #25, #28, #29, #31. 1 (Worse)-5 (Better): #32, #33, #35. In total 8 subscales calculated by averaging the respective items. Physical functioning: #3 to #12. Role limitations due to physical health: #13 to #16. Role limitations due to emotional problems: #17 to #19. Energy/fatigue: #23, #27, #29, #31. Emotional well-being: #24 to #26, #28, #30. Social functioning: #20, #32. Pain: #21, #22. General health: #1, #33 to #36. |
28 days postoperatively | |
Secondary | Treatment satisfaction | Patient satisfaction regarding the treatment quantified with the use of a Visual Ordinal Scale (1-5). Better outcome: 5, Worse outcome: 1. There will be no subscales or total scores. | 35 days postoperatively | |
Secondary | Treatment acceptance | Patient acceptance regarding the re-application of the treatment quantified with the use of a Visual Ordinal Scale (1-5). Better outcome: 5, Worse outcome: 1. There will be no subscales or total scores. | 35 days postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06406621 -
Laser Hair Depilation Darker Skin Pilonidal Disease
|
N/A | |
Active, not recruiting |
NCT03772873 -
MIPE for Pilonidal Disease
|